NORTHFIELD, IL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LEUKEMIA RESEARCH FOUNDATION, founded in 1951, is a community nonprofit in the Medical Research sector that reported $2.5M in total revenue in fiscal year 2023. Revenue fell 40% from the prior year — a significant decline worth monitoring.
TO CURE LEUKEMIA BY FUNDING INNOVATIVE RESEARCH, AND TO SUPPORT PATIENTS AND FAMILIES.
RESEARCH GRANTS - IN FISCAL YEAR 2024, 10 RESEARCH GRANTS WERE AWARDED TO NEW INVESTIGATORS STUDYING LEUKEMIA OR MDS FROM US-BASED AND INTERNATIONAL MEDICAL INSTITUTIONS. EACH GRANT AWARD IS $150,000...
RESEARCH GRANTS - IN FISCAL YEAR 2024, 10 RESEARCH GRANTS WERE AWARDED TO NEW INVESTIGATORS STUDYING LEUKEMIA OR MDS FROM US-BASED AND INTERNATIONAL MEDICAL INSTITUTIONS. EACH GRANT AWARD IS $150,000 OVER A TWO-YEAR PERIOD, WITH TOTAL RESEARCH FUNDING OF $1.5 MILLION. RESEARCH GRANT AWARDS WERE SELECTED BASED ON RECOMMENDATIONS FROM THE FOUNDATION'S INDEPENDENT MEDICAL ADVISORY BOARD AFTER A RIGOROUS GRANT REVIEW PROCESS.
PATIENT EDUCATION AND SUPPORT - PATIENT EDUCATION AND SUPPORT SEVEN PATIENT EDUCATION PROGRAMS WERE PROVIDED FOR PATIENTS AND CAREGIVERS IN FISCAL YEAR 2024. TOPICS WERE SELECTED BASED ON EVALUATION...
PATIENT EDUCATION AND SUPPORT - PATIENT EDUCATION AND SUPPORT SEVEN PATIENT EDUCATION PROGRAMS WERE PROVIDED FOR PATIENTS AND CAREGIVERS IN FISCAL YEAR 2024. TOPICS WERE SELECTED BASED ON EVALUATION RESPONSES FROM PAST EDUCATION PROGRAMS AND FEEDBACK FROM PATIENT ADVISORY COMMITTEE MEMBERS. PROGRAMS INCLUDED THE ANNUAL NEW & EMERGING TREATMENTS SERIES (4 WEBINARS), LEUKEMIA Q&A (CHRONIC AND ACUTE WEBINARS) AND A WEBINAR FOCUSED ONCLINICAL TRIALS. A TOTAL OF 916 PARTICIPANTS REGISTERED FOR THE PATIENT EDUCATION PROGRAMS AND FEEDBACK WAS VERY POSITIVE WITH 91% OF THOSE WHO RESPONDED TO A POST-EVENT SURVEY REPORTING THAT THEY WOULD ATTEND A FUTURE EVENT. 88% RATED THE PROGRAM CONTENT VERY GOOD OR EXCELLENT AND OVER 74% SAID THEY WOULD USE THE INFORMATION THEY LEARNED IN THEIR TREATMENT DECISIONS.
PATIENT GRANT PROGRAM - IN FISCAL YEAR 2024, 85 FINANCIAL ASSISTANCE GRANTS OF UP TO $1,500 WERE AWARDED TO PATIENTS. THIS NEED-BASED PROGRAM ASSISTS LEUKEMIA PATIENTS AND THEIR FAMILIES BY EASING...
PATIENT GRANT PROGRAM - IN FISCAL YEAR 2024, 85 FINANCIAL ASSISTANCE GRANTS OF UP TO $1,500 WERE AWARDED TO PATIENTS. THIS NEED-BASED PROGRAM ASSISTS LEUKEMIA PATIENTS AND THEIR FAMILIES BY EASING THE FINANCIAL BURDEN THAT COMES WITH A LEUKEMIA DIAGNOSIS SO THE FOCUS CAN BE ON HEALTH AND TREATMENT. GRANT AWARDS CAN BE USED FOR ANY EXPENSE, INCLUDING MEDICAL BILLS, MEDICATIONS, TRANSPORTATION AND LODGING EXPENSES, RENT, FOOD, AND MORE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $2,495,610 | $4,193,244 | -0.4% |
| Expenses | $2,610,071 | $3,582,485 | -0.3% |
| Net Income | $-114,461 | $610,759 | -1.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| BLAKE BRANDWEIN | PRESIDENT | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| GERALD BRIN | TREASURER | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| PATTY MIX | SECRETARY | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| ROBERT GRABEMANN | GENERAL COUNSEL | 0.50 |
Director
|
$0 | $0 | $0 |
| TAMAR UZIEL | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| JAIME MORAN | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| JOE GARBARSKI | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| TODD HOLMES | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| FRANK MARTINEZ | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| LARRY MIX | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| RANDI SCHULLO | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| STEVE WILENSKY | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| SAVYON AMIT | VICE PRESIDENT | 0.50 |
Officer
Director
|
$0 | $0 | $0 |
| RONG CHEN | AT LARGE MEMBER | 0.50 |
Director
|
$0 | $0 | $0 |
| KEVIN RADELET | EXECUTIVE DIRECTOR | 37.50 |
Officer
|
$153,786 | $19,349 | $173,135 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $2,495,610 | $2,610,071 | $6,882,073 | $-114,461 |
| 2023 | $4,193,244 | $3,582,485 | $6,864,748 | $610,759 |
| 2022 | $2,910,174 | $2,501,059 | $5,035,074 | $409,115 |
| 2021 | $2,562,072 | $2,472,196 | $4,522,929 | $89,876 |
| 2020 | $2,620,594 | $2,460,482 | $4,154,136 | $160,112 |
| 2019 | $2,386,635 | $2,371,139 | $3,878,638 | $15,496 |
Compare LEUKEMIA RESEARCH FOUNDATION with other nonprofits in Illinois and across the country.